Response to Letter to the Editor: "p.Val804Met, the Most Frequent Pathogenic Mutation in RET, Confers a Very Low Lifetime Risk of Medullary Thyroid Cancer"

Affiliations

• ¹ Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom.
• ² William Harvey Research Institute, Queen Mary University, London, United Kingdom.
• ³ National Cancer Registration and Analysis Service, Public Health England, London, United Kingdom.
• ⁴ Department of Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
• ⁵ Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, United Kingdom.